Caricamento...

Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity

Reovirus is a naturally occurring oncolytic virus currently in early clinical trials. However, the rapid induction of neutralizing antibodies represents a major obstacle to successful systemic delivery. This study addresses, for the first time, the ability of cellular carriers in the form of T cells...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Gene Ther
Autori principali: Ilett, EJ, Prestwich, RJ, Kottke, T, Errington, F, Thompson, JM, Harrington, KJ, Pandha, HS, Coffey, M, Selby, PJ, Vile, RG, Melcher, AA
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4562026/
https://ncbi.nlm.nih.gov/pubmed/19282847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2009.29
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !